220
Participants
Start Date
March 31, 2011
Primary Completion Date
April 30, 2011
Study Completion Date
October 31, 2012
Filgrastim (Eurofarma)
Filgrastim will be given at the daily dose of 5 µg/kg body weight, subcutaneously. The weight considered will be the actual weight, for patients weighing up to 120 kg.
Filgrastim (Granulokine, Amgen)
Granulokine will be given at the daily dose of 5 µg/kg body weight, subcutaneously. The weight considered will be the actual weight, for patients weighing up to 120 kg.
Hospital de Clinicas de Porto Alegre, Porto Alegre
Hospital Nossa Senhora da Conceição, Porto Alegre
CEPHO - Faculdade de Medicina do ABC, Santo André
Casa de Saúde Santa Marcelina, São Paulo
Centro de Referência da Saúde da Mulher, São Paulo
IAVC - Instituto de Cancer Arnaldo Vieira de Carvalho, São Paulo
Lead Sponsor
Eurofarma Laboratorios S.A.
INDUSTRY